Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

EF and PXE not closely related.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

Androgenetic alopecia is common in north Anatolia, affecting more men than women.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Early balding at 40 increases prostate cancer risk.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Erbium YAG laser treatment, combined with conventional therapy, can effectively reduce hair loss and promote hair growth in men with androgenetic alopecia.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Laser treatment for hair loss works equally well on different skin types, but more research is needed for very dark skin.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Muscles and nerves that cause goosebumps also help control hair growth.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

The microneedle patch with quercetin, zinc, and copper effectively promotes hair regrowth for androgenic alopecia.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

More severe hair loss worsens quality of life in men.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.